论文部分内容阅读
本文介绍了β-受体阻滞剂倍他乐克在心脏病中的临床应用 ,着重介绍了其临床作用机制、适应征、剂量、用法及不良反应等。总结了其对充血性心力衰竭 (CHF)的临床作用中所取得可喜的成绩 ,尤其是明显改善了 CHF的心功能、存活率和生命质量 ,并能够预防和治疗左室在心衰之前的心肌细胞重构 ,减轻心肌重量 ,使心脏几何形状趋向正常 ,给心衰病人带来了希望。
This article introduces the clinical application of β-blocker Betaloc in heart disease, and focuses on its clinical mechanism, indications, dosage, usage and adverse reactions. Summarized its satisfactory results in the clinical role of congestive heart failure (CHF), especially significantly improved CHF heart function, survival and quality of life, and can prevent and treat left ventricular myocardial heart failure before Cell remodeling, reducing myocardial weight, so that the geometric shape of the heart tends to normal, heart failure patients have brought hope.